Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation.
暂无分享,去创建一个
[1] L. Freedman,et al. DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. , 1994, Molecular endocrinology.
[2] P. Reitsma,et al. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Collins,et al. Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .
[4] E. C. Anderson,et al. A Differential Screen for Ligand-Regulated Genes: Identification of HoxA10 as a Target of Vitamin D3 Induction in Myeloid Leukemic Cells , 1998, Molecular and Cellular Biology.
[5] L. Freedman,et al. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance. , 1996, Biochemistry.
[6] G. Sauvageau,et al. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. , 1995, Experimental hematology.
[7] P. Lomedico,et al. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3. , 1995, Molecular endocrinology.
[8] H Zola,et al. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. , 1983, Leukemia research.
[9] D. Kufe,et al. Expression of the jun-B gene during induction of monocytic differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[10] James M. Roberts,et al. Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.
[11] H. Sakagami,et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. DeLuca,et al. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Collins,et al. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.
[14] G. Hannon,et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.
[15] H. Erdjument-Bromage,et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. , 1998, Genes & development.
[16] H. Pitot,et al. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures. , 1985, Cancer research.
[17] U. Gullberg,et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. , 1983, Cancer research.
[18] L. Freedman,et al. Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription , 1997, Molecular and cellular biology.
[19] L. Freedman,et al. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers , 1994, Molecular and cellular biology.
[20] James M. Roberts,et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.
[21] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[22] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[23] L. Freedman,et al. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo , 1996, Molecular and cellular biology.
[24] R. Eisenman,et al. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.
[25] L. Freedman,et al. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor , 1995, Molecular and cellular biology.
[26] S. Collins,et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Reitsma,et al. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite , 1983, Nature.
[28] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[29] M. Haussler,et al. A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter , 1996, Molecular and cellular biology.
[30] D. Solomon,et al. Activation of the fructose 1,6-bisphosphatase gene by 1,25-dihydroxyvitamin D3 during monocytic differentiation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Obeid,et al. Transcriptional regulation of protein kinase C by 1,25-dihydroxyvitamin D3 in HL-60 cells. , 1990, The Journal of biological chemistry.
[32] Z. Darżynkiewicz,et al. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells , 1989, Cell.
[33] D. Kufe,et al. Expression of the c-fms proto-oncogene during human monocytic differentiation , 1985, Nature.